Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pacira BioSciences, Inc. | 29,520 | reported | 09 Jun 2021 | tx 6+120,800−4,980 |
| HEPALIFE TECHNOLOGIES INC | 7,887 | reported | 03 May 2019 | tx 4+92,095 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2021 | GRANT_AWARD | Pacira BioSciences, Inc. | 6,000 | 0.00 USD | |
| 09 Jun 2021 | GRANT_AWARD | Pacira BioSciences, Inc. | 15,000 | 0.00 USD | deriv |
| 08 Jun 2021 | SALE | Pacira BioSciences, Inc. | 2,600 | 61.14 USD | |
| 02 Jun 2021 | SALE | Pacira BioSciences, Inc. | 2,380 | 62.12 USD | |
| 02 Jun 2020 | GRANT_AWARD | Pacira BioSciences, Inc. | 28,500 | 0.00 USD | |
| 02 Jun 2020 | GRANT_AWARD | Pacira BioSciences, Inc. | 71,300 | 0.00 USD | deriv |
| 03 May 2019 | GRANT_AWARD | HEPALIFE TECHNOLOGIES INC | 3,943 | — | deriv |
| 03 May 2019 | GRANT_AWARD | HEPALIFE TECHNOLOGIES INC | 56,407 | — | deriv |
| 03 May 2019 | GRANT_AWARD | HEPALIFE TECHNOLOGIES INC | 7,887 | — | deriv |
| 03 May 2019 | GRANT_AWARD | HEPALIFE TECHNOLOGIES INC | 23,858 | — | deriv |